OBI Pharma Announces Poster Presentations at the AACR 2025 Annual Meeting for OBI-992 and OBI-902 Antibody-Drug Conjugates (ADCs), GlycOBI ® and ThiOBI ® ADC enabling technologies, the OBI-3424 prodru
Source link
OBI Pharma Announces Poster Presentations at the AACR 2025 Annual Meeting for OBI-992 and OBI-902 Antibody-Drug Conjugates (ADCs), GlycOBI ® and ThiOBI ® ADC enabling technologies, the OBI-3424 prodru
Source link